Pacira BioSciences PCRX Insider Ownership

NASDAQ PCRX
$24.70 +0.59 (+2.45%)
At close: Sep 22, 2026 · 4:00 PM EDT

Insider Holdings by Owner

2.12Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
5.38%
▼-0.0064% pp QoQ
Shares Held by Insiders
2.12Mn
filed for Sep 2026
▼-0.12% QoQ
Shares Outstanding
39.46Mn
39,462,000 shares
Direct Holdings
2.12Mn
Indirect: 0
Net Shares Traded (QoQ)
-2.53K
net selling in Sep 2026
Insiders Holding Shares
28
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

PCRX's three largest insider shareholders as of September 22, 2026 are Frank D. Lee (Chief Executive Officer, 660.83K shares), Jonathan Slonin (Chief Medical Officer, 216.38K shares), David M Stack (Ceo And Chairman, 186.48K shares).

Form 4 Holdings

Insiders Holding PCRX

Insiders 28
Shares held 2.12Mn
Of outstanding 5.38%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Frank D. Lee Chief Executive Officer 660,831 0 660,831 31.1% 13 Feb, 2026
2 Jonathan Slonin Chief Medical Officer 216,384 0 216,384 10.2% 18 Aug, 2026
3 David M Stack Ceo And Chairman 186,481 0 186,481 8.8% 16 Jun, 2023
4 Kristen Williams Chief Administrative Officer 167,062 0 167,062 7.9% 05 Jun, 2026
5 Daryl Gaugler Chief Operating Officer 115,443 0 115,443 5.4% 06 Jan, 2025
6 Shawn Cross Chief Financial Officer 105,341 0 105,341 5.0% 24 Apr, 2026
7 Brendan Teehan Chief Commercial Officer 100,934 0 100,934 4.8% 13 Feb, 2026
8 Lauren Riker Senior Vice President, Finance 62,284 0 62,284 2.9% 12 Jun, 2026
9 Roy Winston Chief Medical Officer 52,440 0 52,440 2.5% 04 Aug, 2023
10 Charles A. Iii Reinhart Chief Financial Officer 51,867 0 51,867 2.4% 13 Jun, 2024
11 Charles Anthony Laranjeira Chief Technical Officer 41,752 0 41,752 2.0% 16 Jun, 2022
12 Dennis Mcloughlin Chief Customer Officer 38,115 0 38,115 1.8% 07 Jun, 2023
13 Mark A. Kronenfeld Director 34,901 0 34,901 1.6% 13 Jun, 2025
14 Ronald J. Jr. Ellis Chief Strategy Officer 30,909 0 30,909 1.5% 07 Jun, 2023
15 Laura Brege Director 30,120 0 30,120 1.4% 12 Jun, 2026
16 Max Reinhardt President, Rest Of World 29,225 0 29,225 1.4% 07 Jun, 2023
17 Mark Froimson Director 26,541 0 26,541 1.2% 12 Jun, 2026
18 Christopher Christie Director 23,059 0 23,059 1.1% 12 Jun, 2026
19 Gary W Pace Director 22,127 0 22,127 1.0% 08 Mar, 2024
20 Michael J. Yang Director 19,798 0 19,798 0.9% 12 Jun, 2026
21 John P Phd Longenecker Director 18,823 0 18,823 0.9% 07 Mar, 2022
22 Alethia Young Director 17,798 0 17,798 0.8% 12 Jun, 2026
23 Marcelo Bigal Director 17,798 0 17,798 0.8% 12 Jun, 2026
24 Yvonne Greenstreet Director 13,247 0 13,247 0.6% 08 Jun, 2022
25 Anthony Molloy Chief Lgl Compliance Officer 12,877 0 12,877 0.6% 07 Jun, 2023
26 Paul J Hastings Director 12,724 0 12,724 0.6% 13 Jun, 2024
27 Abraham Ceesay Director 9,039 0 9,039 0.4% 08 Sep, 2025
28 Samit Hirawat Director 6,405 0 6,405 0.3% 12 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,692 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
17 Aug, 2026 Jonathan Slonin Chief Medical Officer Disposed S 3,040 $23.23 $70.62K 216,384 Direct
10 Jun, 2026 Michael J. Yang Director Acquired A 6,405 $0.00 $0 19,798 Direct
10 Jun, 2026 Samit Hirawat Director Acquired A 6,405 $0.00 $0 6,405 Direct
10 Jun, 2026 Laura Brege Director Acquired A 6,405 $0.00 $0 30,120 Direct
10 Jun, 2026 Alethia Young Director Acquired A 6,405 $0.00 $0 17,798 Direct
10 Jun, 2026 Thomas G Wiggans Director Acquired A 32,675 $0.00 $0 32,675 Direct
10 Jun, 2026 Marcelo Bigal Director Acquired A 6,405 $0.00 $0 17,798 Direct
11 Jun, 2026 Lauren Riker Senior Vice President, Finance Disposed S 6,115 $23.50 $143.70K 62,284 Direct
10 Jun, 2026 Mark Froimson Director Acquired A 6,405 $0.00 $0 26,541 Direct
10 Jun, 2026 Christopher Christie Director Acquired A 6,405 $0.00 $0 23,059 Direct
10 Jun, 2026 Alethia Young Director Acquired A 10,891 $0.00 $0 10,891 Direct
10 Jun, 2026 Christopher Christie Director Acquired A 10,891 $0.00 $0 10,891 Direct
10 Jun, 2026 Michael J. Yang Director Acquired A 10,891 $0.00 $0 10,891 Direct
10 Jun, 2026 Laura Brege Director Acquired A 10,891 $0.00 $0 10,891 Direct
10 Jun, 2026 Marcelo Bigal Director Acquired A 10,891 $0.00 $0 10,891 Direct
10 Jun, 2026 Samit Hirawat Director Acquired A 10,891 $0.00 $0 10,891 Direct
10 Jun, 2026 Mark Froimson Director Acquired A 10,891 $0.00 $0 10,891 Direct
03 Jun, 2026 Lauren Riker Senior Vice President, Finance Disposed F 3,187 $22.32 $71.13K 68,399 Direct
03 Jun, 2026 Jonathan Slonin Chief Medical Officer Disposed F 4,728 $22.32 $105.53K 218,912 Direct
03 Jun, 2026 Kristen Williams Chief Administrative Officer Disposed F 8,528 $22.32 $190.34K 177,321 Direct